These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


685 related items for PubMed ID: 20616683

  • 1. Clinical characteristics of endophthalmitis after an injection of intravitreal antivascular endothelial growth factor.
    Mezad-Koursh D, Goldstein M, Heilwail G, Zayit-Soudry S, Loewenstein A, Barak A.
    Retina; 2010; 30(7):1051-7. PubMed ID: 20616683
    [Abstract] [Full Text] [Related]

  • 2. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
    Chaudhary KM, Romero JM, Ezon I, Fastenberg DM, Deramo VA.
    Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
    [Abstract] [Full Text] [Related]

  • 3. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA, Post-Injection Endophthalmitis (PIE) Study Team.
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [Abstract] [Full Text] [Related]

  • 4. Changes in Management Based on Vitreous Culture in Endophthalmitis After Intravitreal Anti-vascular Endothelial Growth Factor Injection.
    Patel SN, Storey PP, Pancholy M, Obeid A, Wibbelsman TD, Levin H, Hsu J, Garg SJ, Dunn JP, Vander JF.
    Am J Ophthalmol; 2019 Nov; 207():224-231. PubMed ID: 31201794
    [Abstract] [Full Text] [Related]

  • 5. Bleb-associated endophthalmitis: clinical characteristics and visual outcomes.
    Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB.
    Ophthalmology; 2004 Aug; 111(8):1495-503; discussion 1503. PubMed ID: 15288977
    [Abstract] [Full Text] [Related]

  • 6. Endophthalmitis After Intravitreal Injections: Incidence, Presentation, Management, and Visual Outcome.
    Dossarps D, Bron AM, Koehrer P, Aho-Glélé LS, Creuzot-Garcher C, FRCR net (FRenCh Retina specialists net).
    Am J Ophthalmol; 2015 Jul; 160(1):17-25.e1. PubMed ID: 25892127
    [Abstract] [Full Text] [Related]

  • 7. Acute endophthalmitis after cataract surgery: 250 consecutive cases treated at a tertiary referral center in the Netherlands.
    Pijl BJ, Theelen T, Tilanus MA, Rentenaar R, Crama N.
    Am J Ophthalmol; 2010 Mar; 149(3):482-7.e1-2. PubMed ID: 20053391
    [Abstract] [Full Text] [Related]

  • 8. Endophthalmitis caused by Streptococcus pneumoniae.
    Miller JJ, Scott IU, Flynn HW, Smiddy WE, Corey RP, Miller D.
    Am J Ophthalmol; 2004 Aug; 138(2):231-6. PubMed ID: 15289132
    [Abstract] [Full Text] [Related]

  • 9. Open globe injuries with positive intraocular cultures: factors influencing final visual acuity outcomes.
    Lieb DF, Scott IU, Flynn HW, Miller D, Feuer WJ.
    Ophthalmology; 2003 Aug; 110(8):1560-6. PubMed ID: 12917173
    [Abstract] [Full Text] [Related]

  • 10. Endogenous endophthalmitis: a 10-year review of culture-positive cases in northern China.
    Zhang H, Liu Z.
    Ocul Immunol Inflamm; 2010 Apr; 18(2):133-8. PubMed ID: 20370344
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of safety for bilateral same-day intravitreal injections of antivascular endothelial growth factor therapy.
    Lima LH, Zweifel SA, Engelbert M, Sorenson JA, Slakter JS, Cooney MJ, Klancnik JM, Yannuzzi LA, Freund KB.
    Retina; 2009 Oct; 29(9):1213-7. PubMed ID: 19934815
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.
    Yamashiro K, Tsujikawa A, Miyamoto K, Oh H, Otani A, Tamuara H, Ooto S, Sasahara M, Iwama D, Yoshimura N.
    Retina; 2010 Mar; 30(3):485-90. PubMed ID: 19952993
    [Abstract] [Full Text] [Related]

  • 14. Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review.
    Hoevenaars NE, Gans D, Missotten T, van Rooij J, Lesaffre E, van Meurs JC.
    Ophthalmologica; 2012 Mar; 228(3):143-7. PubMed ID: 22796790
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Culture-proven endogenous endophthalmitis: clinical features and visual acuity outcomes.
    Schiedler V, Scott IU, Flynn HW, Davis JL, Benz MS, Miller D.
    Am J Ophthalmol; 2004 Apr; 137(4):725-31. PubMed ID: 15059712
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. MICROBIAL SPECTRUM AND OUTCOMES OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION VERSUS PARS PLANA VITRECTOMY.
    Garg SJ, Dollin M, Storey P, Pitcher JD, Fang-Yen NH, Vander J, Hsu J, Post-Injection Endophthalmitis Study Team.
    Retina; 2016 Feb; 36(2):351-9. PubMed ID: 26200514
    [Abstract] [Full Text] [Related]

  • 19. Endophthalmitis following intravitreal injections.
    Irigoyen C, Ziahosseini K, Morphis G, Stappler T, Heimann H.
    Graefes Arch Clin Exp Ophthalmol; 2012 Apr; 250(4):499-505. PubMed ID: 22048244
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.